MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CCCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

C4 Therapeutics (CCCC) Ownership - Who owns C4 Therapeutics?

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
104
Web
https://www.c4therapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
455.54M
P/E Ratio
N/A
Total Cash
235.67M
Projected Growth
N/A
Total Debt
58.45M
Revenue
34.86M
Risk (Beta)
3.76
Dividend Yield
N/A
Total Cash/Share
2.13
Total Debt/Equity
N/A
Revenue/Share
0.36 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CCCC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CCCC
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
490 Arsenal Way
Phone
+1 617 231-0700
Employees
104
Web
https://www.c4therapeutics.com